home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 04, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 457 active entries

Maine Biotechnology Services, Inc.

1037R Forest Avenue
Portland, ME 04103
United States of America, Maine
Toll free: 800-925-9476

Phone: 207-797-5454
Fax: 207-797-5595

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

The cornerstone of antibody and assay development at MBS is our technical team approach to project design and planning. The MBS antibody development plan focuses on the timely generation of data from large fusion screens that allow for the identification of quality antibody candidates.  A rigorous set of innovative and thorough screening tools are creatively developed and executed to meet dynamic customer goals with data-driven decision making. If the goals of a project change during the course of development, MBS will use accumulated data to efficiently shift focus to meet the new goals. Our mission is to use these strategies to go beyond limited contract services and be a comprehensive partner in antibody and assay method development.  MBS saves customers money and compresses timelines of the most complex projects. We also offer pre-made antibodies for further manufacturing purposes. Please visit our website at mainebiotechnology.com

Selected Categories:

Product Company   Service Company
Biopharma
- General
Biotech
- General
Diagnostics
- Immunoassay
- in vitro
Pharmaceutical
- Research
Supplier
- Miscellaneous
Contract
- Services

Last update of this entry: September 12, 2017

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.